Hackman Jeffrey S.
- SEC CIK
- 0001926254
No open-market purchases or sales filed in the past year.
Current role at each company
- FENC Fennec Pharmaceuticals Inc.Chief Executive Officeras of Aug 31, 2026
- CMRA Comera Life Sciences Holdings, Inc.See Remarks.as of Sep 28, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hackman Jeffrey S. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
FENC Fennec Pharmaceuticals Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2025 (view filing) | May 16-19 | 3 days | Hackman Jeffrey S.Chief Executive Officer | PPurchase | +15.0K | $6.97 | +$104.6K | New position15.0K after | 2 lots |
CMRA Comera Life Sciences Holdings, Inc.
See Remarks.1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2022 (view filing) | Sep 9 | 3 days | Hackman Jeffrey S.See Remarks | PPurchase | +47.6K | $2.06 | +$98.1K | New position47.6K after |